SWX:NOVNPharmaceuticals
Assessing Novartis (SWX:NOVN) Valuation After Strong Multi‑Year Shareholder Returns
Novartis (SWX:NOVN) shares have quietly moved higher over the past month and past 3 months, putting recent performance and current valuation metrics in focus for investors watching this large Swiss pharmaceutical group.
See our latest analysis for Novartis.
Zooming out, the share price is at CHF 111.52 with a 1 year total shareholder return of 27.79% and a 5 year total shareholder return of 71.01%, suggesting momentum has been building rather than fading over time.
If Novartis has you...